Skip to main content
CNXU logo

Conexeu Sciences Inc.

CNXUNASDAQHealthcareBiotechnology

$3.06Today:- (-)

As of Oct 16, 2026 close

Market cap
$106.54M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.05$18.79
Volume (live)
-
Avg. volume (3M)
279.08K

Conexeu Sciences (CNXU) Balance Sheet

As of Oct 31, 2025 (end of fiscal 2025), Conexeu Sciences reported total assets of $7.69M and total liabilities of $336.02K. Shareholders' equity was $7.35M, up 7642.6% from $94.96K a year earlier.

Conexeu Sciences Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Conexeu Sciences Inc. (CNXU) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023
Period endingOct 2025Oct 2024Oct 2023
Current Assets
Cash and Cash Equivalents4.810.31-
Short-Term Investments0.07--
Cash & Short-Term Investments4.810.31-
Accounts Receivable2.07--
Inventory---
Other Current Assets2.580.03-
Total Current Assets7.460.35-
Non-Current Assets
Property, Plant & Equipment (Net)0.01--
Intangible Assets0.180.19-
Other Non-Current Assets0.04--
Total Non-Current Assets0.230.19-
Total Assets7.690.53-
Current Liabilities
Accounts Payable0.260.32-
Accrued Liabilities0.080.01-
Other Current Liabilities0.000.01-
Total Current Liabilities0.340.34-
Non-Current Liabilities
Long-Term Debt-0.10-
Other Non-Current Liabilities---
Total Non-Current Liabilities-0.10-
Total Liabilities0.340.440.04
Stockholders' Equity
Common Stock0.020.01-
Retained Earnings-4.52-0.60-
Additional Paid-in Capital11.860.68-
Shares Outstanding20.9220.92-
Total Stockholders' Equity7.350.09-0.04
Total Liabilities & Equity7.690.53-

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Conexeu Sciences Balance Sheet

What are Conexeu Sciences's total assets?

Conexeu Sciences reported total assets of $7.69M as of Oct 31, 2025, up 1340.0% from $533.94K a year earlier. Total liabilities were $336.02K.

What is Conexeu Sciences's shareholders' equity?

Conexeu Sciences's shareholders' equity was $7.35M as of Oct 31, 2025, or about $0.35 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition